ArticleAdvanced materials (Deerfield Beach, Fla.)2026
Bioorthogonal Anchor-and-Lock of Probiotic Biofilms on Diverse Biomaterials to Combat Delayed Implant-Associated Infection.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Bacterial adhesion and biofilm formation on implants remain a leading cause of device failure, and delayed-onset infections become refractory to antibiotics once mature biofilms form. Probiotic biofilms offer a promising alternative to conventional antimicrobial coatings, but clinical translation is hindered by the lack of a stable, substrate-generalizable immobilization method. Here we presented a broadly applicable "anchor-and-lock" strategy that covalently tethered probiotic biofilms to diverse implants via bioorthogonal SPAAC reaction. A mussel-inspired adhesive peptide functionalized with DBCO served as the surface anchor, while L. casei metabolically labeled with azide groups became the click-ready lock. The resulting coatings formed uniformly on titanium, polyurethane, silicone rubber, and polypropylene, exhibiting long-term stability. The biofilm operated through a dual-phase antimicrobial mechanism, including an initial bactericidal phase (≥96% killing of S. aureus) mediated by lactic acid and hydrogen peroxide release, followed by a sustained anti-adhesive phase that prevented pathogen colonization. RNA-sequencing revealed that the coating downregulated S. aureus adhesion-associated genes while suppressing carbohydrate transport and metabolic pathways. In clinically relevant delayed-infection models in bone and bladder, functionalized implants prevented infection, mitigated inflammation, and promoted tissue integration, effects absent on unmodified controls. This SPAAC-mediated strategy offers a broad approach to mitigating implant-associated infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.